Milestone Scientific, Inc. (MLSS): Price and Financial Metrics

Milestone Scientific, Inc. (MLSS): $1.04

0.01 (+0.97%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add MLSS to Watchlist
Sign Up

MLSS Price/Volume Stats

Current price $1.04 52-week high $1.27
Prev. close $1.03 52-week low $0.41
Day low $1.01 Volume 270,000
Day high $1.07 Avg. volume 92,958
50-day MA $0.85 Dividend yield N/A
200-day MA $0.75 Market Cap 72.80M

MLSS Stock Price Chart Interactive Chart >

MLSS Stock Summary

  • For MLSS, its debt to operating expenses ratio is greater than that reported by merely 8.62% of US equities we're observing.
  • MLSS's price/sales ratio is 7.95; that's higher than the P/S ratio of 86.4% of US stocks.
  • Revenue growth over the past 12 months for MILESTONE SCIENTIFIC INC comes in at -13.67%, a number that bests only 14.56% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to MLSS, based on their financial statements, market capitalization, and price volatility, are INMD, HNST, EVOK, SIBN, and UTRS.
  • MLSS's SEC filings can be seen here. And to visit MILESTONE SCIENTIFIC INC's official web site, go to www.milestonescientific.com.

MLSS Valuation Summary

  • In comparison to the median Healthcare stock, MLSS's price/sales ratio is 60.78% higher, now standing at 8.2.
  • MLSS's price/earnings ratio has moved down 7.1 over the prior 243 months.

Below are key valuation metrics over time for MLSS.

Stock Date P/S P/B P/E EV/EBIT
MLSS 2023-05-23 8.2 7.6 -8.8 -8.5
MLSS 2023-05-22 8.4 7.8 -9.1 -8.7
MLSS 2023-05-19 8.3 7.6 -8.9 -8.6
MLSS 2023-05-18 8.3 7.6 -8.9 -8.6
MLSS 2023-05-17 8.1 7.5 -8.7 -8.4
MLSS 2023-05-16 7.5 6.9 -8.0 -7.7

MLSS Growth Metrics

    Its 5 year cash and equivalents growth rate is now at -73.96%.
  • Its 5 year net income to common stockholders growth rate is now at -50.8%.
  • Its year over year revenue growth rate is now at 53.89%.
Over the past 33 months, MLSS's revenue has gone up $1,036,501.

The table below shows MLSS's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 9.411002 -3.221857 -7.85378
2022-06-30 9.303536 -4.135996 -7.925184
2022-03-31 10.08091 -4.557275 -7.747171
2021-12-31 10.30471 -4.017581 -6.818317
2021-09-30 9.670744 -6.376852 -6.776149
2021-06-30 8.808621 -6.556074 -6.223931

MLSS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MLSS has a Quality Grade of C, ranking ahead of 36.73% of graded US stocks.
  • MLSS's asset turnover comes in at 0.423 -- ranking 112th of 186 Medical Equipment stocks.
  • TNDM, TFX, and PEN are the stocks whose asset turnover ratios are most correlated with MLSS.

The table below shows MLSS's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.423 0.616 -2.177
2021-03-31 0.315 0.637 -2.538
2020-12-31 0.325 0.666 -3.651
2020-09-30 0.411 0.683 -7.765
2020-06-30 0.616 0.698 30.088
2020-03-31 1.274 0.690 6.927

Milestone Scientific, Inc. (MLSS) Company Bio


Milestone Scientific Inc. operates as a medical technology company. The Company manufactures, markets, and sells computer-controlled local anesthetic delivery systems for plastic surgery, podiatry, dermatology, and orthopedics. Milestone Scientific serves medical sector worldwide.


MLSS Latest News Stream


Event/Time News Detail
Loading, please wait...

MLSS Latest Social Stream


Loading social stream, please wait...

View Full MLSS Social Stream

Latest MLSS News From Around the Web

Below are the latest news stories about MILESTONE SCIENTIFIC INC that investors may wish to consider to help them evaluate MLSS as an investment opportunity.

Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within The Pain and Rehabilitation Medical Group in Torrance, California

Follows successful evaluation by Dr. Fabian Proano, MD including complex thoracic proceduresROSELAND, N.J., May 16, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery systems that provide painless and precise injections, today announced that it has commenced sales of CompuFlo® Epidural disposables into The Pain and Rehabilitation Medical Group in Torrance, California. Adoption of the technology by this clinic follows a successful eva

Yahoo | May 16, 2023

Milestone Scientific Achieves Revenue of $2.6 Million and Provides Business Update for the First Quarter of 2023

Reports 12% increase in gross profit for the first quarter of 2023ROSELAND, N.J., May 11, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the first quarter ended March 31, 2023. Arjan Haverhals, CEO and President of Milestone Scientific, stated, “We achieved solid revenues of $2.6 million for the first qu

Yahoo | May 11, 2023

Milestone Scientific Announces Successful Epidural Steroid Injection Procedures Under New AMA CPT Guidelines for Artificial Intelligence (AI) Assisted Pain Management Surgery

ROSELAND, N.J., May 10, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, as well as AI-assisted medical technology, today announced the successful completion of the first series of epidural steroid injections (ESI) using the CompuFlo Epidural System by physicians under the new American Medical Association (AMA) Current Procedural Terminology (CPT®) guidelines for AI-assiste

Yahoo | May 10, 2023

Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within the Sports and Spine Clinic in Oregon

Follows successful evaluation by Dr. Jimmy D. Huebert, MD, including Epidural Steroid Injection (ESI) procedures in lumbar, thoracic and cervical thoracic junction of the spineROSELAND, N.J., May 09, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery systems that provide painless and precise injections, today announced that it has commenced sales of CompuFlo® Epidural disposables into The Sports and Spine Center in Tualatin, Oregon.

Yahoo | May 9, 2023

Milestone Scientific Schedules First Quarter 2023 Financial Results and Business Update Conference Call

ROSELAND, N.J., May 05, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Thursday, May 11, 2023, to discuss the company’s financial results for the first quarter ended March 31, 2023, as well as the company’s corporate progress and other developments. The conference call will be available via tel

Yahoo | May 5, 2023

Read More 'MLSS' Stories Here

MLSS Price Returns

1-mo 40.54%
3-mo 31.65%
6-mo 52.94%
1-year 2.97%
3-year -43.48%
5-year 25.30%
YTD 116.67%
2022 -76.70%
2021 -2.83%
2020 52.52%
2019 318.67%
2018 -71.86%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!